The methodologies to assess the effectiveness of non-pharmaceutical interventions during COVID-19: a systematic review Nicolas BanholzerAdrian LisonWerner Vach REVIEW Open access 24 September 2022 Pages: 1003 - 1024
Years of life lost during the Covid-19 pandemic in Sweden considering variation in life expectancy by level of geriatric care Marcus EbelingEnrique AcostaKarin Modig COVID-19 Open access 20 September 2022 Pages: 1025 - 1034
The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years Scott A. McDonaldGiske R. LagerweijJacco Wallinga COVID-19 Open access 11 August 2022 Pages: 1035 - 1047
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study Clément MathieuElodie PambrunAntoine Pariente COVID-19 21 September 2022 Pages: 1049 - 1059
SARS-CoV-2 infections in professional orchestra and choir musicians—a prospective cohort study Anne BerghöferGabriele RotterStefan N. Willich COVID-19 Open access 29 September 2022 Pages: 1061 - 1070
Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study Georges BucyibarutaMarta BlangiardoGaryfallos Konstantinoudis COVID-19 Open access 19 September 2022 Pages: 1071 - 1081
Re: Carrat et al. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based “CONSTANCES” cohort Alexander Samuel CORRESPONDENCE 26 October 2022 Pages: 1083 - 1084
The Authors' Reply Fabrice CarratJean-Claude DesenclosMarie Zins CORRESPONDENCE 26 October 2022 Pages: 1085 - 1086
Cohort profile: the Food Chain Plus (FoCus) cohort Corinna GeislerKristina SchlichtMatthias Laudes COHORT PROFILE Open access 16 October 2022 Pages: 1087 - 1105
Framework and baseline examination of the German National Cohort (NAKO) Annette PetersGerman National Cohort (NAKO) ConsortiumJohannes Zschocke COHORT PROFILE Open access 19 October 2022 Pages: 1107 - 1124